Reassessing physician interactions with pharmaceutical companies: A response to Murayama et al. and analysis of survey discrepancies
Akihiko Ozaki(Jyoban Hospital of Tokiwa Foundation), Michio Murakami(Fukushima Medical University), Michioki Endo(Hyogo Prefectural Awaji Medical Center), Yoshitake Takebayashi(Fukushima Medical University), Hiroaki Saito(Sendai Shakai Hoken Hospital)
Cited by 0
Related Papers
Postnuclear disaster evacuation and chronic health in adults in Fukushima, Japan: a long-term retrospective analysis
|BMJ Open|2016|98
Qualitative Investigation into the Mental Health of Healthcare Workers in Japan during the COVID-19 Pandemic
|International Journal of Environmental Research and Public Health|2022|82
RETRACTED: Association between hearing aid use and all-cause and cause-specific dementia: an analysis of the UK Biobank cohort
|The Lancet Public Health|2023|79
COVID-19: challenges faced by Nepalese migrants living in Japan
|BMC Public Health|2021|70